dead cat bounce? Elective surgery in most hospitals are deferred for COVID-19, in USA. COVID-19 is worsening in the US. No known cure.
PME's software is linked to elective surgeries.
surely a downgrade in EPS in FY20, and unknown for FY21 depending on the covid-19, so thats nearly 1-2 years affected.
Price too high @ $20, nearly 100 p/e ratio and 0.5% dividend yield, is not compelling.
Even pre-COVID 19, EPS was forecast up to 40c-50c range for FY22/FY23, so thats till a 40 p/e ratio @ $20, which is high.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$328.25 |
Change
6.740(2.10%) |
Mkt cap ! $34.28B | |||
| Open | High | Low | Value | Volume |
| $319.00 | $329.11 | $316.00 | $48.64M | 149.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18 | $327.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $328.79 | 238 | 2 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| PME (ASX) Chart |